SecBot SecBot
SECBOTREPLAY Home › Report › YARW

YARW · Ameriprise 8.6% passive stake

Yarrow Bioscience, Inc. · SC 13G filed Nov 16, 2026 at 09:47 ET

At the news

NEUTRALIMPACT 3/10

SC 13G filed Nov 16, 2026 at 09:47 ET

Ameriprise Financial disclosed an 8.6% passive beneficial ownership stake in Yarrow Bioscience as of September 30, 2026, primarily through its Columbia Small Cap Growth Fund (6.3%). This adds to a series of recent 13G filings by other institutions following Yarrow's September 2026 equity offering, with no activist intent indicated.

  • Ameriprise Financial, Inc. disclosed a 8.6% beneficial ownership stake in Yarrow Bioscience as of September 30, 2026.
  • The stake comprises 739,538 shares of common stock, with 539,115 shares held by Columbia Small Cap Growth Fund (6.3%).
  • The filing is a passive Schedule 13G under Rule 13d-1(b), certifying no intent to influence control.
  • This follows recent 13G filings by Bellevue Group (10.6%), Spruce Street Capital (6.4%), and others after Yarrow's $172.5M September 2026 equity offering.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access